Australia markets open in 6 hours 3 minutes

MedX Health Corp (MDX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.0350-0.0050 (-12.50%)
At close: 02:14PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 6.43M
Enterprise value 9.74M
Trailing P/E N/A
Forward P/E 23.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.47
Price/book (mrq)N/A
Enterprise value/revenue 18.94
Enterprise value/EBITDA -2.19

Trading information

Stock price history

Beta (5Y monthly) -0.01
52-week change 3-66.67%
S&P500 52-week change 3-16.88%
52-week high 30.1300
52-week low 30.0350
50-day moving average 30.0458
200-day moving average 30.0643

Share statistics

Avg vol (3-month) 381.49k
Avg vol (10-day) 341.16k
Shares outstanding 5183.7M
Implied shares outstanding 6N/A
Float 8176.18M
% held by insiders 12.00%
% held by institutions 10.02%
Shares short (14 Sept 2022) 4609
Short ratio (14 Sept 2022) 40.01
Short % of float (14 Sept 2022) 4N/A
Short % of shares outstanding (14 Sept 2022) 40.00%
Shares short (prior month 28 July 2022) 411.89k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin 0.00%
Operating margin (ttm)-875.65%

Management effectiveness

Return on assets (ttm)-173.30%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)514.52k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-2.40%
Gross profit (ttm)N/A
Net income avi to common (ttm)-5.61M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)40.49k
Total cash per share (mrq)0
Total debt (mrq)3.35M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.19
Book value per share (mrq)-0.03

Cash flow statement

Operating cash flow (ttm)-2.92M
Levered free cash flow (ttm)-1.61M